aflibercept
Showing 26 - 50 of 521
Learn More About How Drug Aflibercept Works in Canadian Reduced
Active, not recruiting
- Myopic Choroidal Neovascularization
- Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
-
Multiple Locations, CanadaMany Locations
Jul 25, 2022
Neovascular Glaucoma Trial in Aurora (Aflibercept)
Completed
- Neovascular Glaucoma
- Aflibercept
-
Aurora, ColoradoRocky Mountain Lions Eye Institute
Feb 16, 2022
Wet Age-related Macular Degeneration Trial in Bern (Aflibercept, Brolucizumab, early treat and extend (T&E))
Enrolling by invitation
- Wet Age-related Macular Degeneration
- Aflibercept
- +2 more
-
Bern, SwitzerlandBerner Augenklinik am Lindenhofspital
May 13, 2022
Neovascular (Wet) Age-related Macular Degeneration Trial (Aflibercept(BAY86-5321, Eylea))
Not yet recruiting
- Neovascular (Wet) Age-related Macular Degeneration
- Aflibercept(BAY86-5321, Eylea)
- (no location specified)
Jul 22, 2022
Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV
Recruiting
- Polypoidal Choroidal Vasculopathy
- +2 more
- Intravitreal aflibercept injection
-
Seoul, Korea, Republic ofJae Hui Kim
Dec 20, 2022
Aflibercept Injection in Japanese Neovascular Glaucoma (NVG)
Recruiting
- Neovascular Glaucoma
- Aflibercept (Eylea, BAY86-5321)
-
Multiple Locations, JapanMany locations
Aug 17, 2022
Diabetic Macular Edema Trial in Palo Alto (Intravitreal Aflibercept)
Withdrawn
- Diabetic Macular Edema
- Intravitreal Aflibercept
-
Palo Alto, CaliforniaByers Eye Institute
Apr 21, 2022
Diabetic Macular Edema With Intravitreal Aflibercept Injection
Active, not recruiting
- Diabetic Macular Edema
- Aflibercept Injection [Eylea]
-
South Dartmouth, MassachusettsAdvanced Eye Centers
Feb 17, 2022
Use of Aflibercept Injections Into Eye for Treatment of Eye
Recruiting
- Retinal Disease
- Aflibercept (BAY86-5321, Eylea)
-
Multiple Locations, MexicoMany locations
Aug 22, 2022
Non-Ischemic Central Retinal Vein Occlusion With Macular Edema Trial in Qina (intravitreal injection of Ranibizumab,
Recruiting
- Non-Ischemic Central Retinal Vein Occlusion With Macular Edema
- intravitreal injection of Ranibizumab
- +3 more
-
QinÄ, Qena, EgyptAhmed Ali Ahmed Amer
Mar 15, 2022
Intravitreal Aflibercept in Diabetic Macular Edema and/or
Completed
- Macular Edema
- Aflibercept (Eylea, BAY86-5321)
-
Multiple Locations, China
- +10 more
Nov 10, 2022
Neovascular Age-Related Macular Degeneration Trial in Worldwide (Ranibizumab, Aflibercept, Port Delivery System with ranibizumab
Suspended
- Neovascular Age-Related Macular Degeneration
- Ranibizumab
- +2 more
-
Capital Federal, Argentina
- +9 more
Nov 8, 2022
Retinal Detachment With Multiple Breaks, Unspecified Eye, Proliferative Vitreoretinopathy Trial in Philadelphia (Intravitreal
Recruiting
- Retinal Detachment With Multiple Breaks, Unspecified Eye
- Proliferative Vitreoretinopathy
- Intravitreal aflibercept injection
- Sham control
-
Philadelphia, PennsylvaniaWills Eye Hospital
May 2, 2022
Maximum Treatment Interval With Aflibercept T&E
Recruiting
- Neovascular Age-related Macular Degeneration
- Aflibercept Injection [Eylea]
-
Taipei, TaiwanShin Kong Memorial Wu Ho-Su Hospital
Apr 19, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial in Canada,
Active, not recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +20 more
- Pembrolizumab
- Ziv-Aflibercept
-
Tampa, Florida
- +8 more
Jan 3, 2023
Exudative Age-related Macular Degeneration Trial (intravitreal injection)
Completed
- Exudative Age-related Macular Degeneration
- intravitreal injection
- (no location specified)
Apr 19, 2022
Wet Age-related Macular Degeneration Trial in United States (Eyp-1901, Aflibercept 2Mg/0.05Ml Inj,Oph)
Recruiting
- Wet Age-related Macular Degeneration
- Eyp-1901
- Aflibercept 2Mg/0.05Ml Inj,Oph
-
Melbourne, Florida
- +4 more
Aug 18, 2022
Diabetic Retinopathy Trial in Montemorelos (Intravitreal bevacizumab or intravitreal ziv-aflibercept)
Completed
- Diabetic Retinopathy
- Intravitreal bevacizumab or intravitreal ziv-aflibercept
-
Montemorelos, Nuevo Leon, MexicoHospital La Carlota
Nov 20, 2021
Aflibercept in Routine Clinical Practice in Diabetic Macular
Completed
- Macular Edema
- Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321)
- Anti-VEGF therapies including: Eylea Aflibercept, VEGF Trap-Eye, BAY86-5321) and Ophthalmologicals / Antineovascularisation agents (S01LA05)
-
Multiple Locations, United Kingdom(unnamed)
Nov 1, 2021
Diabetic Macular Edema Trial in Beijing (9MW0813, Aflibercept)
Recruiting
- Diabetic Macular Edema
- 9MW0813
- Aflibercept
-
Beijing, Beijing, ChinaBeijing tongren hospital affliated to capital medical university
Apr 5, 2022
Diabetic Macular Edema Trial in Beijing (9MW0813, Aflibercept)
Completed
- Diabetic Macular Edema
- 9MW0813
- Aflibercept
-
Beijing, Beijing, ChinaBeijing tongren hospital affliated to capital medical university
Apr 5, 2022
Diabetic Macular Edema Trial in United States (intravitreous aflibercept, Bevacizumab + Deferred Aflibercept Group)
Completed
- Diabetic Macular Edema
- intravitreous aflibercept
- Bevacizumab + Deferred Aflibercept Group
-
Campbell, California
- +53 more
Nov 28, 2022
Diabetic Macular Edema Trial in China (Brolucizumab, Aflibercept)
Active, not recruiting
- Diabetic Macular Edema
- Brolucizumab
- Aflibercept
-
Guangzhou, Guangdong, China
- +23 more
Jan 20, 2023
Neovascular Age-Related Macular Degeneration Trial in China (Brolucizumab 6mg, Aflibercept 2 mg)
Recruiting
- Neovascular Age-Related Macular Degeneration
- Brolucizumab 6mg
- Aflibercept 2 mg
-
Guangzhou, Guangdong, China
- +30 more
Jan 20, 2023
Chorioretinal Vascular Disease Trial in Houston, The Woodlands (Intravitreal Aflibercept Injection (IAI))
Completed
- Chorioretinal Vascular Disease
- Intravitreal Aflibercept Injection (IAI)
-
Houston, Texas
- +1 more
Aug 18, 2021